TrialSignal
Clinical trial intelligence report
Randomized, 2-Way Crossover Bioequivalence Study Finasteride 5 mg Tablet and Proscar Administrated as 1 x 5 mg Tablet in Healthy Subjects Under Fasting Conditions.
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT00870480
Status
COMPLETED
Phase
PHASE1
Sponsor
Actavis Inc.
Executive brief
Investment-Ready Snapshot
This clinical trial, sponsored by Actavis Inc., aimed to evaluate the bioequivalence of Finasteride 5 mg tablets compared to Proscar under fasting conditions in healthy male subjects. The study was completed in November 2004 with 26 participants enrolled in a randomized, 2-way crossover design.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00870480
Indication
Healthy
Modality
small molecule
Target
Finasteride
Intervention
Finasteride 5 mg Tablet, single dose, Proscar® 5 mg Tablet, single dose
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.